首页 > 最新文献

Perfusion-Uk最新文献

英文 中文
Hereditary spherocytosis in a neonate during cardiac surgery. 新生儿心脏手术过程中的遗传性球形红细胞增多症。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-06-29 DOI: 10.1177/02676591251357431
Rebecca Richardson, Richard Crook

Hereditary spherocytosis (HS) is a rare inherited haemolytic anaemia. This case report outlines a neonatal patient with presumed HS requiring cardiopulmonary bypass (CPB) and the whole blood exchange transfusion carried out in the immediate pre bypass setting to ensure a successful outcome.

遗传性球形红细胞增多症(HS)是一种罕见的遗传性溶血性贫血。本病例报告概述了一个新生儿患者推定HS需要体外循环(CPB)和全血交换输血进行立即预搭桥设置,以确保成功的结果。
{"title":"Hereditary spherocytosis in a neonate during cardiac surgery.","authors":"Rebecca Richardson, Richard Crook","doi":"10.1177/02676591251357431","DOIUrl":"10.1177/02676591251357431","url":null,"abstract":"<p><p>Hereditary spherocytosis (HS) is a rare inherited haemolytic anaemia. This case report outlines a neonatal patient with presumed HS requiring cardiopulmonary bypass (CPB) and the whole blood exchange transfusion carried out in the immediate pre bypass setting to ensure a successful outcome.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"225-227"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between venous to arterial carbon dioxide tension gap and clinical outcome in cardiac surgery patients: A systematic review and meta-analysis. 心脏手术患者静脉到动脉二氧化碳张力间隙与临床结果的关系:一项系统回顾和荟萃分析。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-05-23 DOI: 10.1177/02676591251344858
Dan Lin, Hongying Luo, Feng Long, Meng-Han Liu, Yan Zhang, Ting Liu, Rong-Hua Zhou

BackgroundCardiac surgery is associated with increased risk of major adverse outcomes. Venous to arterial carbon dioxide tension gap (Pv-aCO2 gap) showed significant prognostic value of non-cardiac surgery, while their prognostic value after cardiopulmonary bypass (CPB) remains controversial.MethodsWe conducted a systematic research of PubMed, MEDLINE, EMBASE and Web of science electronic database and ClinicalTrials.gov to analysis the association between high Pv-aCO2 gap and adverse outcomes in adult cardiac surgery patients. Random effect model was used to pool data.ResultsEight studies (n = 2136 patients) were enrolled. High Pv-aCO2 gap was mainly defined as Pv-aCO2 ≥ 6-8 mmHg. In cardiac surgery, high Pv-aCO2 gap was not associated with increased hospital mortality (odds ratio, 0.63; 95% CI, 0.17-2.32; p = 0.49)), but was related with higher ICU mortality (odds ratio, 5.27; 95% CI, 2.31-12.00; p < 0.001), higher incidence of major complications (p < 0.05), longer ICU length of stay (p = 0.03) and prolonged ventilation time in the ICU (p < 0.001). Moreover, high Pv-aCO2 gap was linked to postoperative lower cardiac index (p < 0.01) and lower ScvO2 (p < 0.001). Interesting, high Pv-aCO2 gap was not associated with increased postoperative lactate level and longer hospital length of stay.ConclusionAn elevated Pv-aCO2 gap seems to be associated with adverse outcomes in very short time and indicates tissue hypoperfusion rather than tissue hypoxia. Therefore, interventions aiming at normalizing Pv-aCO2 gap may potentially improve clinical outcomes, while further validation is required.

背景:心脏手术与主要不良后果的风险增加相关。静脉-动脉二氧化碳张力间隙(Pv-aCO2 gap)在非心脏手术中具有重要的预后价值,但其在体外循环(CPB)后的预后价值仍存在争议。方法系统研究PubMed、MEDLINE、EMBASE、Web of science电子数据库和ClinicalTrials.gov,分析成人心脏手术患者高Pv-aCO2间隙与不良结局的关系。采用随机效应模型汇集数据。结果共纳入8项研究(n = 2136例)。高Pv-aCO2间隙主要定义为Pv-aCO2≥6-8 mmHg。在心脏手术中,高Pv-aCO2间隙与医院死亡率增加无关(优势比,0.63;95% ci, 0.17-2.32;p = 0.49)),但与较高的ICU死亡率相关(优势比5.27;95% ci, 2.31-12.00;p < 0.001),主要并发症发生率较高(p < 0.05), ICU住院时间较长(p = 0.03), ICU通气时间延长(p < 0.001)。此外,高Pv-aCO2间隙与术后较低的心脏指数(p < 0.01)和较低的ScvO2 (p < 0.001)有关。有趣的是,高Pv-aCO2间隙与术后乳酸水平升高和住院时间延长无关。结论Pv-aCO2间隙升高可能在极短时间内与不良结局相关,提示组织灌注不足而非组织缺氧。因此,旨在使Pv-aCO2间隙正常化的干预措施可能会改善临床结果,但需要进一步验证。
{"title":"Association between venous to arterial carbon dioxide tension gap and clinical outcome in cardiac surgery patients: A systematic review and meta-analysis.","authors":"Dan Lin, Hongying Luo, Feng Long, Meng-Han Liu, Yan Zhang, Ting Liu, Rong-Hua Zhou","doi":"10.1177/02676591251344858","DOIUrl":"10.1177/02676591251344858","url":null,"abstract":"<p><p>BackgroundCardiac surgery is associated with increased risk of major adverse outcomes. Venous to arterial carbon dioxide tension gap (<i>Pv-aCO</i><sub><i>2</i></sub> gap) showed significant prognostic value of non-cardiac surgery, while their prognostic value after cardiopulmonary bypass (CPB) remains controversial.MethodsWe conducted a systematic research of PubMed, MEDLINE, EMBASE and Web of science electronic database and ClinicalTrials.gov to analysis the association between high <i>Pv-aCO</i><sub><i>2</i></sub> gap and adverse outcomes in adult cardiac surgery patients. Random effect model was used to pool data.ResultsEight studies (<i>n</i> = 2136 patients) were enrolled. High <i>Pv-aCO</i><sub><i>2</i></sub> gap was mainly defined as <i>Pv-aCO</i><sub><i>2</i></sub> ≥ 6-8 mmHg. In cardiac surgery, high <i>Pv-aCO</i><sub><i>2</i></sub> gap was not associated with increased hospital mortality (odds ratio, 0.63; 95% CI, 0.17-2.32; <i>p</i> = 0.49)), but was related with higher ICU mortality (odds ratio, 5.27; 95% CI, 2.31-12.00; <i>p</i> < 0.001), higher incidence of major complications (<i>p < 0.05</i>), longer ICU length of stay (<i>p</i> = 0.03) and prolonged ventilation time in the ICU (<i>p</i> < 0.001). Moreover, high <i>Pv-aCO</i><sub><i>2</i></sub> gap was linked to postoperative lower cardiac index (<i>p < 0</i>.01) and lower <i>ScvO</i><sub><i>2</i></sub> (<i>p</i> < 0.001). Interesting, high <i>Pv-aCO</i><sub><i>2</i></sub> gap was not associated with increased postoperative lactate level and longer hospital length of stay.ConclusionAn elevated <i>Pv-aCO</i><sub><i>2</i></sub> gap seems to be associated with adverse outcomes in very short time and indicates tissue hypoperfusion rather than tissue hypoxia. Therefore, interventions aiming at normalizing <i>Pv-aCO</i><sub><i>2</i></sub> gap may potentially improve clinical outcomes, while further validation is required.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"124-133"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crescent plication of the aortic sinuses of Valsalva. 瓦尔萨尔瓦主动脉窦的新月状褶皱。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-05-22 DOI: 10.1177/02676591251345710
Mazin Ai Sarsam, Georgios T Karapanagiotidis, Ioannis Dimarakis

ObjectiveThe study objective was to describe our experience of performing the relatively simple technique of crescent plication of one or more sinus of Valsalva in various clinical scenarios as an alternative to root replacement and to assess the mid to long term results.MethodsFrom 2006 to 2016 17 patients underwent crescent plication of one or more aortic sinuses in association with other procedures 12 had trileaflet aortic valve (group one) four had bicuspid aortic valve (group two) in addition there was a single patient with Marfan syndrome who presented with acute type A aortic dissection.ResultsCrescent plication resulted in a moderate reduction in root diameter that has remained stable over the study period apart from the Marfan patient who unsurprisingly showed modest root dilation over time.ConclusionsCrescent plication is a relatively simple procedure that reduced root diameter and appears to be stable over time in all but the syndromic patient and can be a viable alternative in situations where full root replacement is judged hazardous.

目的本研究的目的是描述我们在各种临床情况下,将一个或多个Valsalva鼻窦进行相对简单的新月形应用技术作为根置换的替代方法的经验,并评估中长期结果。方法2006年至2016年,17例患者行单侧或多侧主动脉瓣月牙形折叠合并其他手术,其中12例为三瓣主动脉瓣(第一组),4例为二瓣主动脉瓣(第二组),另有1例马凡氏综合征患者表现为急性a型主动脉夹层。结果:除了Marfan患者随着时间的推移表现出适度的根扩张外,螺旋应用导致根直径适度缩小,在整个研究期间保持稳定。结论螺旋扩根术是一种相对简单的方法,可以减少根直径,并且随着时间的推移,除了综合征患者外,对所有患者来说都是稳定的,在全根置换被认为危险的情况下,它是一种可行的替代方法。
{"title":"Crescent plication of the aortic sinuses of Valsalva.","authors":"Mazin Ai Sarsam, Georgios T Karapanagiotidis, Ioannis Dimarakis","doi":"10.1177/02676591251345710","DOIUrl":"10.1177/02676591251345710","url":null,"abstract":"<p><p>ObjectiveThe study objective was to describe our experience of performing the relatively simple technique of crescent plication of one or more sinus of Valsalva in various clinical scenarios as an alternative to root replacement and to assess the mid to long term results.MethodsFrom 2006 to 2016 17 patients underwent crescent plication of one or more aortic sinuses in association with other procedures 12 had trileaflet aortic valve (group one) four had bicuspid aortic valve (group two) in addition there was a single patient with Marfan syndrome who presented with acute type A aortic dissection.ResultsCrescent plication resulted in a moderate reduction in root diameter that has remained stable over the study period apart from the Marfan patient who unsurprisingly showed modest root dilation over time.ConclusionsCrescent plication is a relatively simple procedure that reduced root diameter and appears to be stable over time in all but the syndromic patient and can be a viable alternative in situations where full root replacement is judged hazardous.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"134-140"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mannitol and renal failure during cardiopulmonary bypass. Which of biomarkers should be use? 甘露醇与体外循环期间肾功能衰竭。应该使用哪一种生物标志物?
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-06-24 DOI: 10.1177/02676591251356419
Guillermo Lema
{"title":"Mannitol and renal failure during cardiopulmonary bypass. Which of biomarkers should be use?","authors":"Guillermo Lema","doi":"10.1177/02676591251356419","DOIUrl":"10.1177/02676591251356419","url":null,"abstract":"","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"228-229"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strength in numbers, strength in content: Raising the bar. 数量优势,内容优势:提高标准。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2026-01-19 DOI: 10.1177/02676591261418525
Prakash P Punjabi
{"title":"Strength in numbers, strength in content: Raising the bar.","authors":"Prakash P Punjabi","doi":"10.1177/02676591261418525","DOIUrl":"10.1177/02676591261418525","url":null,"abstract":"","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"117-119"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complex cardiac and orthopedic surgery in a 14-year-old with DiGeorge syndrome from a Jehovah's Witness household: A blood conservation approach.
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-05-22 DOI: 10.1177/02676591251340940
Maria E Hoyos, Mario A O'Connor, Brian Kaufman, Cynthia Keene, Madeline Loftin, Hugo R Martinez, Charles D Fraser, Erin Gottlieb

This case report discusses the management of a 15-year-old Jehovah's Witness (JW) with DiGeorge syndrome, complex congenital heart disease (CHD), and severe neuromuscular scoliosis requiring major orthopedic surgery. Refusal of blood transfusions required preoperative optimization and advanced blood conservation strategies. The patient underwent multiple cardiac surgeries and spinal fusion. This case emphasizes multidisciplinary coordination and blood management strategies for surgical cases with religious restrictions.

​拒绝输血需要术前优化和先进的血液保护策略。患者接受了多次心脏手术和脊柱融合术。本病例强调多学科协调和血液管理策略的外科病例与宗教限制。
{"title":"Complex cardiac and orthopedic surgery in a 14-year-old with DiGeorge syndrome from a Jehovah's Witness household: A blood conservation approach.","authors":"Maria E Hoyos, Mario A O'Connor, Brian Kaufman, Cynthia Keene, Madeline Loftin, Hugo R Martinez, Charles D Fraser, Erin Gottlieb","doi":"10.1177/02676591251340940","DOIUrl":"10.1177/02676591251340940","url":null,"abstract":"<p><p>This case report discusses the management of a 15-year-old Jehovah's Witness (JW) with DiGeorge syndrome, complex congenital heart disease (CHD), and severe neuromuscular scoliosis requiring major orthopedic surgery. Refusal of blood transfusions required preoperative optimization and advanced blood conservation strategies. The patient underwent multiple cardiac surgeries and spinal fusion. This case emphasizes multidisciplinary coordination and blood management strategies for surgical cases with religious restrictions.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"221-224"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of HTK solution in protecting cardiomyocytes against oxidative stress by upregulating Nrf2 during cardiac arrest and resuscitation: a rat model with a right thoracotomy. HTK溶液在心脏骤停和复苏过程中通过上调Nrf2保护心肌细胞免受氧化应激的作用:右开胸大鼠模型
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-06-05 DOI: 10.1177/02676591241307365
BingMei Qiu, Lei Wang, PeiCheng Ding, AnLi Wang, Xing Zhang, Qian Li, ChangTian Wang, ShanWu Feng

IntroductionThe objective of this study was to establish a rat model for cardiopulmonary bypass (CPB) with cardiac arrest and resuscitation and to investigate the regulatory role of HTK solution in protecting cardiomyocytes against oxidative stress by upregulating Nrf2.Methods40 rats were randomly assigned to four groups: the control (Ctrl), the histidine-tryptophan-ketoglutarate (HTK), 4:1 blood cardioplegia (BC) and del Nido cardioplegia (DN) groups. The cardiopulmonary bypass (CPB) procedure was implemented and sustained for a duration of 1 hour. Subsequent to the cessation of CPB, the rats were subjected to monitoring and observation for an additional 2 hours. Following this observation period, the heart and blood samples were procured for subsequent analysis.ResultsThe MDA was significantly higher in the HTK group, BC group, and DN group compared to the Ctrl group. The HTK group had lower MDA levels than the BC group. Regarding MPO activity, it increased in the HTK group, BC group, and DN group relative to the Ctrl group. Both the BC and DN groups exhibited elevated MPO levels compared to the HTK group. SOD levels were significantly lower in the HTK, BC, and DN groups compared to the Ctrl group. The HTK group had higher SOD levels than the BC group. With respect to miRNA-210-3P and Nrf2, the expression were more efficient in the HTK, BC, and DN groups compared to the Ctrl group. The BC and DN groups showed reduced expression efficiency over the HTK group. Western blot analysis indicated that the ratio of Nrf2 target was higher in the HTK group, BC group, and DN group in comparison to the Ctrl group. Both the BC and DN groups had lower protein content compared to the HTK group. Immunohistochemistry scoring of HIF1-α and nuclear Nrf2 revealed higher scores in the HTK, BC, and DN groups compared to the Ctrl group. The HTK group achieved higher scores than both the BC and DN groups.ConclusionVaried degrees of oxidative stress damage were exhibited by three distinct cardioplegia solutions. The HTK group demonstrated a superior antioxidant effect. The protective response of the HTK solution against oxidative stress may be linked to the up-regulation of Nrf2.

本研究旨在建立体外循环(CPB)心脏骤停复苏大鼠模型,探讨HTK溶液通过上调Nrf2对心肌细胞抗氧化应激的调节作用。方法40只大鼠随机分为4组:对照组(Ctrl)、组氨酸-色氨酸-酮戊二酸(HTK)、4:1血停搏(BC)组和德尔尼多停搏(DN)组。实施体外循环(CPB)手术并持续1小时。CPB停止后,再对大鼠进行2小时的监测观察。在这一观察期之后,采集心脏和血液样本进行后续分析。结果HTK组、BC组、DN组MDA均高于对照组。HTK组MDA水平低于BC组。在MPO活性方面,HTK组、BC组和DN组的MPO活性均高于Ctrl组。与HTK组相比,BC组和DN组均表现出MPO水平升高。与Ctrl组相比,HTK组、BC组和DN组的SOD水平明显降低。HTK组SOD水平高于BC组。与Ctrl组相比,HTK、BC和DN组miRNA-210-3P和Nrf2的表达效率更高。BC和DN组的表达效率低于HTK组。Western blot分析显示,HTK组、BC组、DN组Nrf2靶蛋白比例高于Ctrl组。与HTK组相比,BC组和DN组的蛋白质含量都较低。HTK组、BC组和DN组的HIF1-α和核Nrf2免疫组化评分高于对照组。HTK组得分高于BC组和DN组。结论三种不同的停搏液均表现出不同程度的氧化应激损伤。HTK组表现出较好的抗氧化作用。HTK溶液对氧化应激的保护作用可能与Nrf2的上调有关。
{"title":"Role of HTK solution in protecting cardiomyocytes against oxidative stress by upregulating Nrf2 during cardiac arrest and resuscitation: a rat model with a right thoracotomy.","authors":"BingMei Qiu, Lei Wang, PeiCheng Ding, AnLi Wang, Xing Zhang, Qian Li, ChangTian Wang, ShanWu Feng","doi":"10.1177/02676591241307365","DOIUrl":"10.1177/02676591241307365","url":null,"abstract":"<p><p>IntroductionThe objective of this study was to establish a rat model for cardiopulmonary bypass (CPB) with cardiac arrest and resuscitation and to investigate the regulatory role of HTK solution in protecting cardiomyocytes against oxidative stress by upregulating Nrf2.Methods40 rats were randomly assigned to four groups: the control (Ctrl), the histidine-tryptophan-ketoglutarate (HTK), 4:1 blood cardioplegia (BC) and del Nido cardioplegia (DN) groups. The cardiopulmonary bypass (CPB) procedure was implemented and sustained for a duration of 1 hour. Subsequent to the cessation of CPB, the rats were subjected to monitoring and observation for an additional 2 hours. Following this observation period, the heart and blood samples were procured for subsequent analysis.ResultsThe MDA was significantly higher in the HTK group, BC group, and DN group compared to the Ctrl group. The HTK group had lower MDA levels than the BC group. Regarding MPO activity, it increased in the HTK group, BC group, and DN group relative to the Ctrl group. Both the BC and DN groups exhibited elevated MPO levels compared to the HTK group. SOD levels were significantly lower in the HTK, BC, and DN groups compared to the Ctrl group. The HTK group had higher SOD levels than the BC group. With respect to miRNA-210-3P and Nrf2, the expression were more efficient in the HTK, BC, and DN groups compared to the Ctrl group. The BC and DN groups showed reduced expression efficiency over the HTK group. Western blot analysis indicated that the ratio of Nrf2 target was higher in the HTK group, BC group, and DN group in comparison to the Ctrl group. Both the BC and DN groups had lower protein content compared to the HTK group. Immunohistochemistry scoring of HIF1-α and nuclear Nrf2 revealed higher scores in the HTK, BC, and DN groups compared to the Ctrl group. The HTK group achieved higher scores than both the BC and DN groups.ConclusionVaried degrees of oxidative stress damage were exhibited by three distinct cardioplegia solutions. The HTK group demonstrated a superior antioxidant effect. The protective response of the HTK solution against oxidative stress may be linked to the up-regulation of Nrf2.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"197-211"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neonatal hepatic failure for early-onset group B streptococcal sepsis successfully treated using hemoperfusion with Jafron cartridge during V-A ECMO support. 在V-A ECMO支持下使用Jafron血液灌流成功治疗早发性B组链球菌败血症的新生儿肝功能衰竭。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 DOI: 10.1177/02676591251366418
Elisa Barberi, Giacomo Bianchi, Vitali Pak, Cornel Marusceac, Dorela Haxhiademi, Nadia Assanta, Michele Guarino, Paolo Antonio Del Sarto

IntroductionManagement of neonatal Group B Streptococcal (GBS) sepsis with multi-organ failure requires innovative approaches when conventional therapies prove insufficient.Case ReportA term neonate developed severe respiratory failure and septic shock from GBS infection, necessitating veno-arterial extracorporeal membrane oxygenation (V-A ECMO) initiation at 24 hours of life. During ECMO support, the patient developed hepatic dysfunction with severe hyperbilirubinemia (peak total/direct bilirubin: 36.9/31.6 mg/dL). A Jafron HA60 hemoadsorption cartridge was integrated into the ECMO circuit, resulting in a 38% bilirubin reduction within 24 hours. Despite complications including lung atelectasis, renal dysfunction, and nosocomial COVID-19, the patient was successfully decannulated after 15 days, extubated after 24 days, and discharged home after 48 days with normal neurological outcomes.DiscussionThis case highlights the application of hemoadsorption technology for managing hepatic failure in neonatal ECMO.ConclusionHemoadsorption therapy represents a promising adjunctive treatment for neonates with severe hyperbilirubinemia during ECMO support.

新生儿B组链球菌(GBS)脓毒症合并多器官功能衰竭的治疗需要创新的方法,当常规治疗证明不足时。病例报告:1例足月新生儿因GBS感染出现严重呼吸衰竭和感染性休克,需要在出生24小时开始静脉-动脉体外膜氧合(V-A ECMO)。在ECMO支持期间,患者出现肝功能障碍并伴有严重的高胆红素血症(峰值总胆红素/直接胆红素:36.9/31.6 mg/dL)。将Jafron HA60血液吸附盒整合到ECMO回路中,导致24小时内胆红素降低38%。尽管出现了肺不张、肾功能不全和院内感染COVID-19等并发症,但患者在15天后成功脱管,24天后拔管,48天后出院,神经系统预后正常。本病例强调了血液吸附技术在新生儿ECMO中处理肝衰竭的应用。结论血液吸附治疗是重度高胆红素血症新生儿在ECMO支持期间的一种有前景的辅助治疗方法。
{"title":"Neonatal hepatic failure for early-onset group B streptococcal sepsis successfully treated using hemoperfusion with Jafron cartridge during V-A ECMO support.","authors":"Elisa Barberi, Giacomo Bianchi, Vitali Pak, Cornel Marusceac, Dorela Haxhiademi, Nadia Assanta, Michele Guarino, Paolo Antonio Del Sarto","doi":"10.1177/02676591251366418","DOIUrl":"10.1177/02676591251366418","url":null,"abstract":"<p><p>IntroductionManagement of neonatal Group B Streptococcal (GBS) sepsis with multi-organ failure requires innovative approaches when conventional therapies prove insufficient.Case ReportA term neonate developed severe respiratory failure and septic shock from GBS infection, necessitating veno-arterial extracorporeal membrane oxygenation (V-A ECMO) initiation at 24 hours of life. During ECMO support, the patient developed hepatic dysfunction with severe hyperbilirubinemia (peak total/direct bilirubin: 36.9/31.6 mg/dL). A Jafron HA60 hemoadsorption cartridge was integrated into the ECMO circuit, resulting in a 38% bilirubin reduction within 24 hours. Despite complications including lung atelectasis, renal dysfunction, and nosocomial COVID-19, the patient was successfully decannulated after 15 days, extubated after 24 days, and discharged home after 48 days with normal neurological outcomes.DiscussionThis case highlights the application of hemoadsorption technology for managing hepatic failure in neonatal ECMO.ConclusionHemoadsorption therapy represents a promising adjunctive treatment for neonates with severe hyperbilirubinemia during ECMO support.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":"41 2","pages":"120-123"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147327788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative hemoglobin changes following ultrafiltration in cardiac patients. 心脏患者超滤术后血红蛋白的变化。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-05-28 DOI: 10.1177/02676591251344852
Ethan Forsberg, Douglas Smego, Kirk Bingham, Christopher Blaylock

IntroductionThis retrospective study investigated the relationship between differing thresholds of Conventional Ultrafiltration (CUF) and postoperative hemoglobin (HGB) in cardiac surgery cases involving cardiopulmonary bypass.MethodsThe study utilized EPIC and STS data for patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). It included three groups: those without CUF (n = 106), low CUF (volume <20 mL/kg; n = 33), and high CUF (volume ≥20 mL/kg); n = 18). HGB levels were assessed at the following points: Pre-operative, end-bypass, first hour in the ICU, discharge, and 30 days post-procedure. Total intravenous fluid administration at 72 hours postoperatively was also evaluated.ResultsThere was no significant difference between the three groups in HGB pre-operatively, end-bypass, or during the first hour in the ICU. At discharge, the non-CUF group had significantly higher HGB levels than the high CUF group (p = 0.028), and HGB in the low CUF group was not significantly different from the high CUF (p = 0.102) group. At 30 days, HGB in the low CUF group was significantly higher than those with high CUF (p = 0.022). Additionally, HGB levels in the non-CUF group were not significantly different than those with high CUF (0.078). Surprisingly, there was no difference in total IV fluid volume administered at 72 hours post-op (p = 0.181) between any of the groups.ConclusionsLow CUF is superior to no CUF, and high CUF in the preservation of hemoglobin levels - even at 30 days. Additionally, CUF of any volume was not associated with increased IV fluid resuscitation postoperatively.

摘要本回顾性研究探讨了体外循环心脏手术患者常规超滤(CUF)阈值与术后血红蛋白(HGB)的关系。方法对心脏手术合并体外循环(CPB)患者进行EPIC和STS数据分析。分为无CUF组(n = 106)、低CUF组(体积n = 33)、高CUF组(体积≥20 mL/kg);N = 18)。HGB水平在以下时间点进行评估:术前、旁路结束、在ICU的第一个小时、出院和术后30天。术后72小时静脉输液总剂量也进行了评估。结果三组患者术前、旁路终末及入住ICU后1小时HGB差异无统计学意义。出院时,非CUF组HGB水平显著高于高CUF组(p = 0.028),低CUF组HGB水平与高CUF组无显著差异(p = 0.102)。30 d时,低CUF组HGB显著高于高CUF组(p = 0.022)。此外,非CUF组的HGB水平与高CUF组无显著差异(0.078)。令人惊讶的是,在术后72小时内,两组之间的静脉输液总量没有差异(p = 0.181)。结论慢速CUF优于无CUF,高速CUF保存血红蛋白水平-即使在30 d。此外,任何体积的CUF与术后静脉液体复苏的增加无关。
{"title":"Postoperative hemoglobin changes following ultrafiltration in cardiac patients.","authors":"Ethan Forsberg, Douglas Smego, Kirk Bingham, Christopher Blaylock","doi":"10.1177/02676591251344852","DOIUrl":"10.1177/02676591251344852","url":null,"abstract":"<p><p>IntroductionThis retrospective study investigated the relationship between differing thresholds of Conventional Ultrafiltration (CUF) and postoperative hemoglobin (HGB) in cardiac surgery cases involving cardiopulmonary bypass.MethodsThe study utilized EPIC and STS data for patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). It included three groups: those without CUF (<i>n</i> = 106), low CUF (volume <20 mL/kg; <i>n</i> = 33), and high CUF (volume ≥20 mL/kg); <i>n</i> = 18). HGB levels were assessed at the following points: Pre-operative, end-bypass, first hour in the ICU, discharge, and 30 days post-procedure. Total intravenous fluid administration at 72 hours postoperatively was also evaluated.ResultsThere was no significant difference between the three groups in HGB pre-operatively, end-bypass, or during the first hour in the ICU. At discharge, the non-CUF group had significantly higher HGB levels than the high CUF group (<i>p</i> = 0.028), and HGB in the low CUF group was not significantly different from the high CUF (<i>p</i> = 0.102) group. At 30 days, HGB in the low CUF group was significantly higher than those with high CUF (<i>p</i> = 0.022). Additionally, HGB levels in the non-CUF group were not significantly different than those with high CUF (0.078). Surprisingly, there was no difference in total IV fluid volume administered at 72 hours post-op (<i>p</i> = 0.181) between any of the groups.ConclusionsLow CUF is superior to no CUF, and high CUF in the preservation of hemoglobin levels - even at 30 days. Additionally, CUF of any volume was not associated with increased IV fluid resuscitation postoperatively.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"182-186"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal membrane oxygenation for systemic lupus erythematosus: An ELSO registry analysis. 体外膜氧合治疗系统性红斑狼疮:ELSO登记分析。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-05-26 DOI: 10.1177/02676591251346069
Maria Pereira, Danielle Guffey, Katherine Doane, Eyal Muscal, Carla Levin, Peter Rycus, Marc Anders, Andrea Ontaneda

The success of extracorporeal membrane oxygenation (ECMO) in treating Systemic Lupus Erythematosus (SLE) and the risk factors associated with mortality remain uncertain. Methods: We describe the survival outcomes at discharge of the largest SLE cohort on ECMO support. We performed a retrospective cohort study of the Extracorporeal Life Support Organization registry database from 2012 to 2022. Pediatric and adult survivor groups were analyzed using descriptive statistics for the primary study outcome of survival to hospital discharge. Risk predictors for survival were determined by logistic regression.Results: We included 48 children and 368 adults with SLE. Overall, 198 patients (54%) survived to hospital discharge, with a survival of 52% and 47% of pediatric and adult patients, respectively.Conclusion: We conclude that ECMO can be considered a life supporting strategy in pediatric and adult SLE patients.

体外膜氧合(ECMO)治疗系统性红斑狼疮(SLE)的成功和与死亡率相关的危险因素仍不确定。方法:我们描述了最大的SLE队列在ECMO支持下的出院生存结果。我们对2012年至2022年的体外生命支持组织注册数据库进行了回顾性队列研究。使用描述性统计方法对儿童和成人幸存者组进行生存至出院的主要研究结果分析。通过逻辑回归确定生存风险预测因子。结果:我们纳入了48名儿童和368名成人SLE患者。总体而言,198名患者(54%)存活至出院,儿科和成人患者的生存率分别为52%和47%。结论:我们的结论是ECMO可以被认为是儿童和成人SLE患者的生命支持策略。
{"title":"Extracorporeal membrane oxygenation for systemic lupus erythematosus: An ELSO registry analysis.","authors":"Maria Pereira, Danielle Guffey, Katherine Doane, Eyal Muscal, Carla Levin, Peter Rycus, Marc Anders, Andrea Ontaneda","doi":"10.1177/02676591251346069","DOIUrl":"10.1177/02676591251346069","url":null,"abstract":"<p><p>The success of extracorporeal membrane oxygenation (ECMO) in treating Systemic Lupus Erythematosus (SLE) and the risk factors associated with mortality remain uncertain. <i>Methods:</i> We describe the survival outcomes at discharge of the largest SLE cohort on ECMO support. We performed a retrospective cohort study of the Extracorporeal Life Support Organization registry database from 2012 to 2022. Pediatric and adult survivor groups were analyzed using descriptive statistics for the primary study outcome of survival to hospital discharge. Risk predictors for survival were determined by logistic regression.<i>Results:</i> We included 48 children and 368 adults with SLE. Overall, 198 patients (54%) survived to hospital discharge, with a survival of 52% and 47% of pediatric and adult patients, respectively.<i>Conclusion:</i> We conclude that ECMO can be considered a life supporting strategy in pediatric and adult SLE patients.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"173-181"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Perfusion-Uk
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1